Everett, WA – February 11, 2011 – SNBL USA, one of the nation’s leading preclinical testing companies, today announced it has selected Instem’s Provantis® preclinical software solution suite as its official integrated data collection system. As part of their initiative to invest in the future, SNBL USA will be using the flexible Provantis solution suite to offer its biotechnology and pharmaceutical clients’ unparalleled quality in both science and service.
To ensure the highest quality data possible in support of the drug development process for all of their clients, SNBL USA will be accessing every module of the integrated Provantis solution suite, including Instem’s Dispense solution for test item control and its latest Data Import module, enabling SNBL USA to seamlessly pull a broad range of external information into Provantis such as Estrous Cycle and Bone Assessment data.
SNBL USA’s evaluation began with Instem’s Toxicology Resource Planning (TRP) solution. Deployed as an integrated module within the Provantis suite or a stand-alone solution, TRP manages studies, resources, equipment, animals and facilities to enable improved study throughput and increased up-time with less administration. Using TRP, SNBL USA will be able to initiate projects more quickly, generate more value from physical assets, and know the status of studies at all times while keeping plans consistent and on track.
“Our cost analysis results indicate the potential for marked reductions in overhead following the implementation of Instem’s entire Provantis solution suite,” states Dr. Hideshi Tsusaki, SNBL USA president. “We were looking for an integrated solution to replace our existing software system, and Provantis exceeded all of our expectations.”
About Provantis®
Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.
About Instem
Instem is a world-leading information solutions provider to the life sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of business intelligence, planning, workflow management, document management and report compilation applications. Instem supports clients around the world through full service offices in the United States, United Kingdom and China. Instem additionally has resource locations in India and a full service distributor based in Japan.
To learn more about Instem solutions and its mission, please visit www.instem.com.
About SNBL USA, Ltd.
Headquartered in Everett, WA, SNBL USA, Ltd. is a preclinical CRO that specializes in nonhuman primate (NHP) and small animal research. Study programs range from regulatory toxicology to customized study designs and disease models. Specialized programs include reproductive toxicology, safety pharmacology, immunotoxicology and carcinogenicity. Through a commitment to investment and excellence, SNBL USA strives to offer the biotechnology and pharmaceutical industries unparalleled quality in both science and service. For additional information call 425.407.0121 or visit www.snblusa.com.
SNBL USA is a wholly-owned subsidiary of Shin Nippon Biomedical Laboratories, Ltd. (SNBL), one of the largest CROs in Japan. Established in 1957, SNBL currently employs approximately 2,000 team members worldwide and provides full service drug development capabilities ranging from preclinical through clinical services.
